Yatin Suneja
Stock Analyst at Guggenheim
(4.96)
# 112
Out of 4,629 analysts
427
Total ratings
60.4%
Success rate
33.8%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ROIV Roivant Sciences | Maintained: Buy | $36 → $42 | $36.34 | +15.58% | 10 | Aug 7, 2026 | |
| CLDX Celldex Therapeutics | Reiterated: Buy | $100 | $41.75 | +139.52% | 10 | Aug 6, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | $90 | $63.36 | +42.05% | 8 | Aug 6, 2026 | |
| AVTX Avalo Therapeutics | Reiterated: Buy | $50 → $48 | $18.32 | +162.01% | 3 | Aug 6, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $800 | $360.76 | +121.75% | 17 | Aug 6, 2026 | |
| OCS Oculis Holding AG | Maintained: Buy | $45 | $12.63 | +256.29% | 3 | Aug 6, 2026 | |
| SION Sionna Therapeutics | Reiterated: Buy | $50 → $60 | $51.04 | +17.55% | 8 | Aug 6, 2026 | |
| DNTH Dianthus Therapeutics | Reiterated: Buy | $200 | $108.92 | +83.62% | 10 | Aug 5, 2026 | |
| SYRE Spyre Therapeutics | Reiterated: Buy | $115 → $130 | $104.91 | +23.92% | 6 | Aug 4, 2026 | |
| ARGX argenx SE | Initiated Coverage: Buy | $1,135 → $1,185 | $865.04 | +36.99% | 26 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,000 → $1,030 | $784.36 | +31.32% | 33 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 → $222 | $163.41 | +35.85% | 14 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $22 | $8.55 | +157.31% | 17 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $260 → $280 | $207.94 | +34.65% | 28 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 | $13.48 | +278.34% | 7 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $76.79 | -2.33% | 3 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 | $130.93 | +33.66% | 10 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $5.97 | +151.47% | 6 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 | $13.89 | +389.56% | 9 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35 | $14.00 | +150.00% | 4 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $32.43 | +69.60% | 3 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 → $62 | $39.95 | +55.19% | 12 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $2.79 | +473.48% | 9 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $34 | $27.60 | +23.19% | 5 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $3.90 | +284.62% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $1.84 | +660.87% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $32.71 | +83.43% | 3 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $1.63 | +758.90% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $245 → $260 | $212.74 | +22.21% | 25 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 → $200 | $98.82 | +102.39% | 6 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $70 | $14.30 | +389.51% | 1 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $128 → $100 | $7.98 | +1,153.13% | 7 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 | $56.61 | +147.31% | 21 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $18.26 | +9.53% | 11 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $35.36 | - | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $4.16 | +525.00% | 11 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $29.21 | n/a | 12 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $45 | $25.62 | n/a | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.60 | n/a | 2 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 2 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.94 | n/a | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.9017 | n/a | 10 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $16.78 | n/a | 1 | May 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.35 | n/a | 2 | May 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $123 | $32.27 | n/a | 7 | Jul 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $0.9075 | n/a | 1 | Jul 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $32 | $16.84 | n/a | 4 | Dec 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $49.76 | n/a | 6 | Oct 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.25 | n/a | 1 | Aug 13, 2014 |
Roivant Sciences
Aug 7, 2026
Maintained: Buy
Price Target: $36 → $42
Current: $36.34
Upside: +15.58%
Celldex Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $100
Current: $41.75
Upside: +139.52%
Xenon Pharmaceuticals
Aug 6, 2026
Reiterated: Buy
Price Target: $90
Current: $63.36
Upside: +42.05%
Avalo Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $50 → $48
Current: $18.32
Upside: +162.01%
Praxis Precision Medicines
Aug 6, 2026
Reiterated: Buy
Price Target: $800
Current: $360.76
Upside: +121.75%
Oculis Holding AG
Aug 6, 2026
Maintained: Buy
Price Target: $45
Current: $12.63
Upside: +256.29%
Sionna Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $50 → $60
Current: $51.04
Upside: +17.55%
Dianthus Therapeutics
Aug 5, 2026
Reiterated: Buy
Price Target: $200
Current: $108.92
Upside: +83.62%
Spyre Therapeutics
Aug 4, 2026
Reiterated: Buy
Price Target: $115 → $130
Current: $104.91
Upside: +23.92%
argenx SE
Aug 4, 2026
Initiated Coverage: Buy
Price Target: $1,135 → $1,185
Current: $865.04
Upside: +36.99%
Aug 3, 2026
Maintained: Buy
Price Target: $1,000 → $1,030
Current: $784.36
Upside: +31.32%
Jul 31, 2026
Maintained: Buy
Price Target: $200 → $222
Current: $163.41
Upside: +35.85%
Jul 31, 2026
Maintained: Buy
Price Target: $25 → $22
Current: $8.55
Upside: +157.31%
Jul 21, 2026
Rated: Buy
Price Target: $260 → $280
Current: $207.94
Upside: +34.65%
Jul 17, 2026
Reiterated: Buy
Price Target: $51
Current: $13.48
Upside: +278.34%
Jul 9, 2026
Reiterated: Buy
Price Target: $75
Current: $76.79
Upside: -2.33%
Jul 1, 2026
Reiterated: Buy
Price Target: $175
Current: $130.93
Upside: +33.66%
Jun 29, 2026
Maintained: Buy
Price Target: $15
Current: $5.97
Upside: +151.47%
Jun 24, 2026
Reiterated: Buy
Price Target: $68
Current: $13.89
Upside: +389.56%
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $14.00
Upside: +150.00%
Jun 5, 2026
Maintained: Buy
Price Target: $55
Current: $32.43
Upside: +69.60%
May 26, 2026
Maintained: Buy
Price Target: $44 → $62
Current: $39.95
Upside: +55.19%
May 15, 2026
Reiterated: Buy
Price Target: $16
Current: $2.79
Upside: +473.48%
May 15, 2026
Reiterated: Buy
Price Target: $32 → $34
Current: $27.60
Upside: +23.19%
May 13, 2026
Maintained: Buy
Price Target: $15
Current: $3.90
Upside: +284.62%
May 8, 2026
Maintained: Buy
Price Target: $14
Current: $1.84
Upside: +660.87%
May 7, 2026
Maintained: Buy
Price Target: $60
Current: $32.71
Upside: +83.43%
May 7, 2026
Maintained: Buy
Price Target: $14
Current: $1.63
Upside: +758.90%
May 4, 2026
Maintained: Buy
Price Target: $245 → $260
Current: $212.74
Upside: +22.21%
Apr 27, 2026
Maintained: Buy
Price Target: $125 → $200
Current: $98.82
Upside: +102.39%
Mar 24, 2026
Initiated Coverage: Buy
Price Target: $70
Current: $14.30
Upside: +389.51%
Mar 13, 2026
Maintained: Buy
Price Target: $128 → $100
Current: $7.98
Upside: +1,153.13%
Mar 4, 2026
Reiterated: Buy
Price Target: $140
Current: $56.61
Upside: +147.31%
Feb 24, 2026
Maintained: Buy
Price Target: $20
Current: $18.26
Upside: +9.53%
Nov 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $35.36
Upside: -
Sep 29, 2025
Reiterated: Buy
Price Target: $26
Current: $4.16
Upside: +525.00%
Feb 27, 2025
Maintained: Hold
Price Target: $20
Current: $29.21
Upside: n/a
Jan 3, 2025
Upgraded: Buy
Price Target: $45
Current: $25.62
Upside: n/a
Dec 11, 2024
Downgraded: Hold
Price Target: n/a
Current: $15.60
Upside: n/a
Sep 21, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 8, 2023
Reiterated: Hold
Price Target: n/a
Current: $4.94
Upside: n/a
Jul 17, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.9017
Upside: n/a
May 31, 2022
Initiated Coverage: Buy
Price Target: $24
Current: $16.78
Upside: n/a
May 15, 2020
Reiterated: Buy
Price Target: $9
Current: $1.35
Upside: n/a
Jul 20, 2018
Reiterated: Buy
Price Target: $115 → $123
Current: $32.27
Upside: n/a
Jul 13, 2018
Initiated Coverage: Buy
Price Target: $12
Current: $0.9075
Upside: n/a
Dec 12, 2017
Reiterated: Buy
Price Target: $21 → $32
Current: $16.84
Upside: n/a
Oct 18, 2017
Rated: Buy
Price Target: n/a
Current: $49.76
Upside: n/a
Aug 13, 2014
Reiterated: Buy
Price Target: n/a
Current: $13.25
Upside: n/a